DURECT Corporation P/B ratio

P/B ratio of DRRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/B ratio growth rates and interactive chart. Measures the relationship between price and book value per share. Book value is the equity or owner's capital that is invested in a business. If a stock has a price of $10 and a book value per share of $10, the ratio is 1. Stock selling below a P/B of 1 can be a bargain, as the market price has declined below the net asset value of the business. It is more applicable to financial companies like banks and insurers, as their assets and liabilities are valued at market and the book value thus more accuraterly represents reality.


Highlights and Quick Summary

Current P/B ratio of DURECT Corporation is 3.28 (as of December 31, 2022)
  • P/B ratio for the quarter ending June 30, 2023 was 22.06 (a 214.31% increase compared to previous quarter)
  • Year-over-year quarterly P/B ratio increased by 481.92%
  • Annual P/B ratio for 2022 was 3.28 (a -14.89% decrease from previous year)
  • Annual P/B ratio for 2021 was 3.86 (a -63.24% decrease from previous year)
  • Annual P/B ratio for 2020 was 10.49 (a -67.34% decrease from previous year)
Visit stockrow.com/DRRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/B ratio of DURECT Corporation

Most recent P/B ratioof DRRX including historical data for past 10 years.

Interactive Chart of P/B ratio of DURECT Corporation

DURECT Corporation P/B ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 22.06 7.02
2022 3.28 3.79 2.98 3.2 3.28
2021 3.86 4.55 5.05 5.27 3.86
2020 10.49 9.95 12.57 21.56 10.49
2019 32.11 16.06 4.38 6.89 32.11
2018 3.84 6.71 8.92 10.81 3.84
2017 6.22 27.42 0.0 45.86 6.22
2016 21.4 14.81 8.46 16.13 21.4
2015 17.6 13.65 12.42 14.04 17.6
2014 4.76 6.97 8.03 4.95 4.76
2013 5.8 5.66 3.51 4.01 5.8
2012 2.24 4.34 2.24

Business Profile of DURECT Corporation

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic